Cargando…

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US

Objectives: Patient preference information (PPI) is gaining recognition among the pharmaceutical industry, regulatory authorities, and health technology assessment (HTA) bodies/payers for use in assessments and decision-making along the medical product lifecycle (MPLC). This study aimed to identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whichello, Chiara, van Overbeeke, Eline, Janssens, Rosanne, Schölin Bywall, Karin, Russo, Selena, Veldwijk, Jorien, Cleemput, Irina, Juhaeri, Juhaeri, Levitan, Bennett, Kübler, Jürgen, Smith, Meredith, Hermann, Richard, Englbrecht, Matthias, Hueber, Axel J., Comanescu, Alina, Harding, Sarah, Simoens, Steven, Huys, Isabelle, de Bekker-Grob, Esther W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759933/ https://www.ncbi.nlm.nih.gov/pubmed/31619989 http://dx.doi.org/10.3389/fphar.2019.01009

Ejemplares similares

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA
por: Janssens, Rosanne, et al.
Publicado: (2019)

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review
por: Janssens, Rosanne, et al.
Publicado: (2019)

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study
por: van Overbeeke, Eline, et al.
Publicado: (2019)

Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison
por: Whichello, Chiara, et al.
Publicado: (2020)

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
por: Janssens, Rosanne, et al.
Publicado: (2023)

Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis
por: Bywall, Karin Schölin, et al.
Publicado: (2018)

Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations
por: Simons, Gwenda, et al.
Publicado: (2022)

Benefit–risk evaluation: the past, present and future
por: Juhaeri, Juhaeri
Publicado: (2019)

Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique
por: Veldwijk, Jorien, et al.
Publicado: (2023)

Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania
por: Simons, Gwenda, et al.
Publicado: (2022)

Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients
por: Bywall, Karin Schölin, et al.
Publicado: (2020)

Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project
por: Falahee, Marie, et al.
Publicado: (2021)

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice
por: Janssens, Rosanne, et al.
Publicado: (2018)

Correction to: Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study
por: Jimenez-Moreno, A. Cecilia, et al.
Publicado: (2021)

Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study
por: Jimenez-Moreno, A. Cecilia, et al.
Publicado: (2021)

Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives
por: van Overbeeke, Eline, et al.
Publicado: (2020)

Discrete choice experiment versus swing-weighting: A head-to-head comparison of diabetic patient preferences for glucose-monitoring devices
por: Whichello, Chiara, et al.
Publicado: (2023)

Predicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study
por: Johnson, Eric S, et al.
Publicado: (2011)

Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance
por: Bate, Andrew, et al.
Publicado: (2019)

The Impact of Video-Based Educational Materials with Voiceovers on Preferences for Glucose Monitoring Technology in Patients with Diabetes: A Randomised Study
por: Smith, Ian P., et al.
Publicado: (2023)

Patients accept therapy using embryonic stem cells for Parkinson’s disease: a discrete choice experiment
por: Bywall, Karin Schölin, et al.
Publicado: (2023)

Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature
por: Kürzinger, Marie-Laure, et al.
Publicado: (2020)

A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project
por: Jimenez-Moreno, Aura Cecilia, et al.
Publicado: (2020)

Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia
por: van Overbeeke, Eline, et al.
Publicado: (2021)

Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population
por: Oliveri, Serena, et al.
Publicado: (2021)

Does It Matter How You Ask? Assessing the Impact of Failure or Effectiveness Framing on Preferences for Antibiotic Treatments in a Discrete Choice Experiment
por: Smith, Ian P, et al.
Publicado: (2022)

Methodological Priorities for Patient Preferences Research: Stakeholder Input to the PREFER Public–Private Project
por: Smith, Ian P., et al.
Publicado: (2021)

Performance assessment of different machine learning approaches in predicting diabetic ketoacidosis in adults with type 1 diabetes using electronic health records data
por: Li, Lin, et al.
Publicado: (2021)

Web-Based Signal Detection Using Medical Forums Data in France: Comparative Analysis
por: Kürzinger, Marie-Laure, et al.
Publicado: (2018)

Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
por: Smith, Ian P, et al.
Publicado: (2023)

Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics
por: Tave, Arlene, et al.
Publicado: (2021)

The Effect of Including an Opt-Out Option in Discrete Choice Experiments
por: Veldwijk, Jorien, et al.
Publicado: (2014)

COVID-19 Contact Tracing Apps: Predicted Uptake in the Netherlands Based on a Discrete Choice Experiment
por: Jonker, Marcel, et al.
Publicado: (2020)

Taking the Shortcut: Simplifying Heuristics in Discrete Choice Experiments
por: Veldwijk, Jorien, et al.
Publicado: (2023)

Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING study
por: van Overbeeke, Eline, et al.
Publicado: (2020)

Patients as research partners in preference studies: learnings from IMI-PREFER
por: Smith, Meredith Y., et al.
Publicado: (2023)

What Factors Influence Non-Participation Most in Colorectal Cancer Screening? A Discrete Choice Experiment
por: de Bekker-Grob, Esther W., et al.
Publicado: (2020)

How to balance valuable innovation with affordable access to medicines in Belgium?
por: Simoens, Steven, et al.
Publicado: (2022)

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients
por: Durosini, Ilaria, et al.
Publicado: (2021)

Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey
por: van Overbeeke, Eline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t11ros4p9go4ibtt3mp6jk4cdi